Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
Globe Newswire•05/08/2026•07:00 ET
0
Whiz Insights
BERKELEY HEIGHTS, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial-stage biotechnology company, today announced that the management team will participate in two upcoming investor conferences in August and September 2026.
Canaccord Genuity 46(th) Annual Growth Conference Fireside Chat Presenter: Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals Location: Boston, Massachusetts Date: August 11, 2026 Presentation Time: 1:30-1:55 p.m. ET
Get started
Create a free account to read the full story.